No Data
Individual stock information.
Kei Pharma <4896.T> is under a stop-high buy order. Keio University School of Medicine, which conducts joint research with the company, announced new research findings on regenerative medicine targeting subacute spinal cord injuries, one of the candidates in the development pipeline for regenerative medicine, on the weekend of the 21st. In the clinical study of regenerative medicine using iPS cell-derived neural progenitor cells, improvements were observed in two out of four patients. Saifuse <4892.T> Tokyo Stock Exchange is utilizing Margin Trading.
The market is soft, with few clues, and profit-taking Sell may be dominant.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to exhibit a weak performance. Last weekend, on the 21st, in the U.S. stock market, the Dow Inc rose slightly by 32.03 points (+0.08%) to 41,985.35 dollars. The lackluster earnings outlook for sporting goods manufacturer Nike (NKE) and logistics company FedEx (FDX), along with notable technical selling due to stock index futures and Single Option settlements, stood out. In contrast, the rise of aircraft manufacturer Boeing (BA) supported the market.
Requio Pharmaceuticals, GDH and others.
＜3133＞ Kaifan Birdman has signed a business consignment contract with ＜7063＞. ＜4169＞ Enechange recorded a subsidy benefit of 0.041 billion yen as non-operating income. ＜4437＞ GDH has increased the Dividends, with a year-end distribution of 4.00 yen per share, up from 3.00 yen. ＜4475＞ HENGGE has established a joint venture (consolidated subsidiary) in the USA. ＜4579＞ Raquoia Pharmaceutical has entered into a capital and business partnership agreement with HK inno.N Corporation (South Korea), through the issuance of new shares via third-party allotment (2.59 million).
Yamato HD, upward revision for 25/3 net profit to 36 billion yen from 18 billion yen.
Yamato HD <9064> announced a revision of its financial estimates for the fiscal year ending March 2025. Net income has been revised upwards from 18 billion yen to 36 billion yen. As part of strengthening balance sheet management, it has resolved to carry out the transfer and leasing (sale and leaseback) of fixed assets. In connection with the transfer of fixed assets, a gain on the sale of fixed assets of 24.2 billion yen is expected to be recorded as special income. 【Positive Evaluation】 <6838> Tamagawa HD Revision | <3321> Mitachi Revision <940>
Key points of interest for the PTS on the 21st = Nippon TV HD, Nissin OilliO, Yamato HD, ETC.
▽Nippon Television Holdings <9404.T> raised its consolidated operating profit Financial Estimates for the fiscal year ending March 2025 from 42 billion yen to 48 billion yen (a 15% increase compared to the previous period). ▽Nissin OilliO <2602.T> lowered its consolidated operating profit Financial Estimates for the fiscal year ending March 2025. A mid-term management plan is also being formulated. ▽Yamato Holdings <9064.T> recorded fixed asset disposal gains in connection with the transfer of fixed assets. The consolidated net profit Financial Estimates for the fiscal year ending March 2025 have been increased. ▽Takahiro Kofu <2676.T> announced a 1-for-2 Stock Split, with a record date of May 31.
Koukandekirukun: Explanatory materials on the revised earnings forecast for the fiscal year ending March 31, 2025 and changes to the shareholder benefit program